M.M.H. Hochstenbag - Brands

Zhang, X., Peeters, S., Huysmans, S., Houben, R., Marcuse, F., Hochstenbag, M., & De Ruysscher, D. (2025). Risk factors and prognostic factors of pleural metastases in thymic epithelial tumors: A narrative review. European Journal of Surgical Oncology, 51(5), Article 109639. https://doi.org/10.1016/j.ejso.2025.109639

Marcuse, F., Dumoulin, D., Hartemink, K., Hochstenbag, M., Burgers, S., Gietema, H. A., Mulders, T. A., Eryigit, E., Maessen, J., Maat, L., Hamid, M. A., von der Thüsen, J., Monkhorst, K., Dingemans, A.-M. C., & Girard, N. (2024). The DETECTION project part 1: An international Delphi survey about diagnostics and treatment of anterior mediastinal cystic lesions. Lung Cancer, 199, Article 108055. https://doi.org/10.1016/j.lungcan.2024.108055

Girard, N., Aix, S. P., Cedres, S., Berghmans, T., Burgers, S., Toffart, A.-C., Popat, S., Janssens, A., Gervais, R., Hochstenbag, M., Silva, M., Burger, I. A., Prosch, H., Stahel, R., Xenophontos, E., Pretzenbaher, Y., Neven, A., & Peters, S. (2023). Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trial. ESMO Open, 8(3), Article 101576. https://doi.org/10.1016/j.esmoop.2023.101576

Marcuse, F., Hoeijmakers, J. G. J., Hochstenbag, M., Hamid, M. A., Keijzers, M., Mane-Damas, M., Martinez-Martinez, P., Verschuuren, J., Kuks, J., Beekman, R., van der Kooi, A. J., van Doorn, P., van Es, M., Maessen, J. J. G., & De Baets, M. H. V. (2023). Outcomes after robotic thymectomy in nonthymomatous versus thymomatous patients with acetylcholine-receptor-antibody-associated myasthenia gravis. Neuromuscular Disorders, 33(5), 417-424. https://doi.org/10.1016/j.nmd.2023.03.005

Remon, J., Villacampa, G., Facchinetti, F., Di Maio, M., Marcuse, F., Tiseo, M., Hochstenbag, M., Hendriks, L. E. L., & Besse, B. (2023). Immune checkpoint blockers in patients with unresectable or metastatic thymic epithelial tumours: A meta-analysis. European Journal of Cancer, 180(1), 117-124. https://doi.org/10.1016/j.ejca.2022.12.005

Marcuse, F., Hochstenbag, M., De Baets, M. H. V., Bootsma, G., Maat, A. P. W. M., Hoeijmakers, J. G. J., Keijzers, M., Abdul Hamid, M., De Ruysscher, D., & Maessen, J. G. (2022). Robotic Thymectomy for Thymomas: A Retrospective Follow-up Study in the Netherlands. Annals of Thoracic Surgery, 114(5), 1886-1894. https://doi.org/10.1016/j.athoracsur.2021.09.056

Angrisani, A., Houben, R., Marcuse, F., Hochstenbag, M., Maessen, J., De Ruysscher, D., & Peeters, S. (2022). "Radiotherapy for thymic epithelial tumors: What is the optimal dose? A systematic review.". Clinical and Translational Radiation Oncology, 34, 67-74. https://doi.org/10.1016/j.ctro.2022.03.005

Marcuse, F., Brandts, L., Moens, D., Damoiseaux, J., Hochstenbag, M., Hoeijmakers, J. G. J., Maessen, J. G., & De Baets, M. (2022). The association between anti-acetylcholine receptor antibody level and clinical improvement in myasthenia gravis. European Journal of Neurology, 29(4), 1187-1197. https://doi.org/10.1111/ene.15238

Marcuse, F., Peeters, S., Herman, K., Vaassen, F., Van Elmpt, W., Maat, A. P. W. M., Praag, J., Billiet, C., Van Schil, P., Lambrecht, M., Van Raemdonck, D., Cao, K., Grigoroiu, M., Girard, N., Hochstenbag, M., Maessen, J., & De Ruysscher, D. (2021). Optimal delineation of the clinical target volume for thymomas in the post-resection setting: A multi-center study. Radiotherapy and Oncology, 165, 8-13. https://doi.org/10.1016/j.radonc.2021.10.007

Marcuse, F., Hochstenbag, M., Hoeijmakers, J. G. J., Hamid, M. A., Damoiseaux, J., Maessen, J., & De Baets, M. (2021). Subclinical myasthenia gravis in thymomas. Lung Cancer, 152, 143-148. https://doi.org/10.1016/j.lungcan.2020.12.010